Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewCourtland is a Philadelphia-based nonprofit healthcare, housing, and social-services organization focused primarily on older adults and other underserved populations. Rather than a drug-development biotech or pharmaceutical company, it operates senior-centered services including affordable housing, senior centers, skilled nursing, rehabilitation, memory support, hospice-related care, and service coordination. The organization manages nearly 600 affordable housing units, three senior centers, and community-based support programs, and its Germantown Home campus includes a 180-bed nursing and rehabilitation facility. NewCourtland positions itself around integrated access to health, housing, and social services for low-income seniors and related vulnerable populations. For biotech/pharma diligence purposes, it should be classified as a healthcare services nonprofit rather than a therapeutic-product developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewCourtland.